Sign In
Buy ICCC
$11.21
+0.150 (+1.36%)
At Close: Jul 31, 2026
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2023
04:05pm, Monday, 13'th Nov 2023
PORTLAND, Maine, Nov. 13, 2023 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets s
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2023
12:15pm, Tuesday, 07'th Nov 2023
Conference Call Scheduled for Tuesday, November 14, 2023 at 9:00 AM ET Conference Call Scheduled for Tuesday, November 14, 2023 at 9:00 AM ET
ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2023
04:05pm, Thursday, 05'th Oct 2023
PORTLAND, Maine, Oct. 05, 2023 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets s
ImmuCell Announces Submission of CMC Technical Section to the FDA
08:00am, Tuesday, 29'th Aug 2023
PORTLAND, Maine, Aug. 29, 2023 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets s
ImmuCell Corporation (ICCC) Q2 2023 Earnings Call Transcript
04:48pm, Friday, 11'th Aug 2023
ImmuCell Corporation (NASDAQ:ICCC ) Q2 2023 Earnings Conference Call August 11, 2023 9:00 AM ET Company Participants Joe Dorame - Lytham Partners, IR Michael Brigham - President and Chief Executive Of
ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2023
04:05pm, Thursday, 10'th Aug 2023
PORTLAND, Maine, Aug. 10, 2023 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets s
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2023
12:00pm, Monday, 07'th Aug 2023
PORTLAND, Maine, Aug. 07, 2023 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets s
ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2023
04:05pm, Tuesday, 11'th Jul 2023
PORTLAND, Maine, July 11, 2023 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets s
ImmuCell Corporation (ICCC) Q1 2023 Earnings Call Transcript
10:00am, Friday, 12'th May 2023
ImmuCell Corporation (NASDAQ:ICCC ) Q1 2023 Earnings Conference Call May 12, 2023 9:00 AM ET Company Participants Joe Diaz - Lytham Partners, IR Michael Brigham - President and CEO Conference Call Par
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2023
06:30am, Thursday, 04'th May 2023
PORTLAND, Maine, May 04, 2023 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets sc
ImmuCell Corporation (ICCC) Q4 2022 Earnings Call Transcript
12:50pm, Wednesday, 22'nd Feb 2023
ImmuCell Corporation (NASDAQ:ICCC ) Q4 2022 Earnings Conference Call February 22, 2023 9:00 AM ET Company Participants Joe Diaz - Lytham Partners, IR Michael Brigham - President and CEO Conference Cal
ImmuCell to Announce Unaudited Financial Results for the Year Ended December 31, 2022
11:55am, Wednesday, 15'th Feb 2023
Conference Call Scheduled for Wednesday, February 22, 2023 at 9:00 AM ET Conference Call Scheduled for Wednesday, February 22, 2023 at 9:00 AM ET
ImmuCell Corporation (ICCC) Q3 2022 Earnings Call Transcript
11:37am, Tuesday, 22'nd Nov 2022
ImmuCell Corporation (NASDAQ:ICCC ) Q3 2022 Earnings Conference Call November 22, 2022 9:00 AM ET Company Participants Joe Diaz - Lytham Partners, IR Michael Brigham - President and CEO Bobbi Jo Brock
ImmuCell to Participate in the Lytham Partners Fall 2022 Investor Conference
09:00pm, Wednesday, 14'th Sep 2022 GlobeNewswire Inc.
PORTLAND, Maine, Sept. 14, 2022 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets
ImmuCell to Participate in the Lytham Partners Fall 2022 Investor Conference
05:00pm, Wednesday, 14'th Sep 2022
PORTLAND, Maine, Sept. 14, 2022 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets s
